FRM
Fox Run Management’s Pacific Biosciences PACB Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
-26,744
| Closed | -$100K | – | 996 |
|
|
2024
Q1 | $100K | Buy |
26,744
+1,056
| +4% | +$3.96K | 0.02% | 702 |
|
|
2023
Q4 | $252K | Buy |
25,688
+2,905
| +13% | +$28.5K | 0.06% | 559 |
|
|
2023
Q3 | $190K | Buy |
+22,783
| New | +$190K | 0.06% | 569 |
|
|
2023
Q1 | – | Sell |
-17,789
| Closed | -$146K | – | 859 |
|
|
2022
Q4 | $146K | Buy |
+17,789
| New | +$146K | 0.06% | 529 |
|
|
2022
Q3 | – | Sell |
-14,173
| Closed | -$63K | – | 770 |
|
|
2022
Q2 | $63K | Buy |
+14,173
| New | +$63K | 0.03% | 486 |
|
|
2016
Q3 | – | Sell |
-15,000
| Closed | -$106K | – | 626 |
|
|
2016
Q2 | $106K | Sell |
15,000
-12,900
| -46% | -$91.2K | 0.05% | 502 |
|
|
2016
Q1 | $237K | Buy |
+27,900
| New | +$237K | 0.16% | 298 |
|